Akroswiss takes a step forward in the interest of patients closing a multi-million CHF Seed-Series Funding Round
Akroswiss is developing an innovative and patented Midazolam-based nasal spray to treat patients suffering from claustrophobia and epileptic seizures. In April, the Swiss start-up has raised several million Swiss Franc in a strategic seed funding round. The funding will fuel R&D to fulfill EMAs requirements to obtain EU marketing authorization for the product.
The majority of Akroswiss’ new funding came from financial investors, the family investment group Linsi, with radiologist and primary user Prof. Dr. med. Bernhard Schuknecht as well as existing investor Walter P. Hölzle also participating in the round. The board has therefore, been extended to seat the new investor groups. Marc Froehlich, former pharma strategy consultant, will operationally lead the company in the role of CEO. Akroswiss will use the new funds to further product development, conduct clinical studies, and initiate the medical device regulatory process to complement EMA’s requirements for data package submission.
Prof. Dr. med. Bernhard Schuknecht highlights: “In our radiology institute Midazolam based nasal spray has been applied for many years during diagnostic examinations. The spray enables adequate resolution of anxiety and sedation and therefore, facilitates patients’ examinations. Akroswiss bi-dose spray is easy to administer and more hygienic than any other solution. Relief of anxiety by endonasal administration is a safe, effective route to improve patients’ comfort and image quality without the necessity of an intravenous line.
An additional advantage of Akroswiss bi-dose nasal spray is the emergency endonasal administration of midazolam in patients with a sudden onset seizure. Thus, a safe route of endonasal administration on an emergency basis may effectively prevent potential harmful injuries and progression into a potential life-threatening seizure status.
To make this product available for more patients in need, a European marketing authorization is required. I believe Akroswiss and its team are best positioned to reach this within reasonable time.”
Akroswiss has successfully developed and tested a unique Bi-dose nasal drug delivery device for Midazolam with a first-class 360° functionality. The development of these Midazolam medicines comes in two independent indications: (1)Product for premedication ahead of diagnostic and therapeutic interventions against claustrophobia and restlessness, (2) product for the rescue treatment in epileptic seizure patients.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210517005059/en/
Contact information
Akroswiss AG
www.akroswiss.ch
Marc Fröhlich
Mail: marc.froehlich@akroswiss.ch
Phone: +41 (0)79 766 88 42
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BearingPoint RegTech and Vizor Software Join Forces: Global RegTech and SupTech Powerhouse Created17.6.2021 09:50:00 CEST | Press release
BearingPoint RegTech (“RegTech”), a leading European provider of innovative regulatory, risk, and supervisory technology solutions, has signed an agreement regarding the acquisition of Vizor Software (“Vizor”). Vizoris a global leader in regulatory and supervisory technology headquartered in Dublin, Ireland. With the newly formed partnership, RegTech and Vizor aim to accelerate their future growth journey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210617005052/en/ Jürgen Lux, CEO BearingPoint RegTech (Photo: Business Wire) The combination of the two companies follows a clear strategic rationale as the companies fit perfectly together and complement each other ideally with their solution portfolios. RegTech and Vizor have a strong track record within the regulatory and supervisory technology space. Furthermore, the two companies serve complimentary geographies. While RegTech can rely on a strong customer base in Germany,
SES Expands Cloud Leadership as Amazon Web Services Direct Connect Partner17.6.2021 08:50:00 CEST | Press release
SES today announced it has joined the Amazon Web Services (AWS) Direct Connect Delivery Partner program. Through a technical and business review process, AWS validated SES’s ability to connect its customers directly to their AWS services over its network of multi-orbit satellites. This provides SES customers flexible, secure, reliable access to their cloud-based applications and services from virtually any location around the world. This is a major advantage to both enterprises and government users who require reliable bandwidth while working in remote locations. SES is the first satellite operator to achieve AWS Direct Connect Partner status. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210616006077/en/ SES Expands Cloud Leadership as Amazon Web Services Direct Connect Partner (Photo: Business Wire) As an AWS Direct Connect Delivery Partner, SES can provide enterprises and governments with dedicated connectivity between v
SIG SolarCAD II: Solar Thermal Delivering 80°C Daily Even in Winter Months17.6.2021 07:47:00 CEST | Press release
The new SIG SolarCAD II solar thermal power plant, designed and installed by the Geneva-based TVP Solar and inaugurated in February this year, has proven its high performance in winter conditions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210616005846/en/ Even covered in snow, TVP Solar thermal panels supply SIG target temperatures and thermal energy (Photo: TVP Solar) More than 157 MWh (1.92 kWh/m²/day) of solar hot water at over 80°C were delivered to the district heat network (CAD) between January and April, i.e. 30% of the annual energy performance target of 516 MWh set between the Services Industriels de Genève (SIG) and TVP Solar. Michel Monnard, thermal director at SIG and project instigator, is delighted: “the solar plant’s performance significantly exceeded our expectations, being remarkably efficient during the cold and poor sunshine winter period when the CAD has the most need for heat.” The TVP solar thermal
C3 AI and NCS Form Strategic Partnership to Deliver Enterprise AI Applications Across Asia-Pacific17.6.2021 06:00:00 CEST | Press release
C3 AI (NYSE:AI), the Enterprise AI application software company, and NCS, a leading technology services provider and member of the Singtel Group, today announced a strategic partnership focused on delivering enterprise AI solutions to clients in Southeast Asia (SEA) and Australia/New Zealand (ANZ) across multiple industries, including telecommunications, government, financial services, transportation, and more. This agreement represents C3 AI’s first strategic partnership with a telecommunications group. NCS will leverage its deep domain experience and technology expertise in serving governments and businesses in SEA and ANZ, investing up to S$10 million to develop and deploy enterprise AI applications created on the C3 AI® Suite. C3 AI’s solutions will also be deployed across Singtel, Optus, and other affiliated telecommunications networks to bring the advantages of enterprise AI to their operations and clients. As the leader in enterprise AI applications, C3 AI’s offerings include th
MicroPort CRM Announces European Launch of Alizea TM and Borea TM Pacemakers With Bluetooth® Connectivity and Streamlined Remote Monitoring17.6.2021 06:00:00 CEST | Press release
MicroPort CRM, a pioneering company in the field of Cardiac Rhythm management, headquartered in France with global operations,announced today the European launch of AlizeaTM and BoreaTM pacemakers after receiving the CE mark under the new Medical Device Regulation (MDR - 2017/745). The devices are equipped with Bluetooth®1 technology for streamlined remote monitoring when paired with the SmartView ConnectTM home monitor. AlizeaTM and BoreaTM connected pacemakers allow cardiologists to monitor the devices remotely, saving patients the need to travel to hospital for a simple routine examination and thus reducing burden on the healthcare system. Today, with more than 500 000 patients per year implanted with a pacemaker across Europe, connected cardiac technologies are needed more than ever. "MicroPort CRM has always been committed to providing medical devices with the most advanced technology and features to improve patient outcomes and reduce the burden on the healthcare system”, said Be
Dialpad Introduces a Smarter, More Reliable Calling Experience for Microsoft Teams Users17.6.2021 01:57:00 CEST | Press release
Dialpad Inc., the industry leader in AI-powered communication and collaboration, today announced its platform integration with Microsoft Teams, a leading solution for team collaboration and engagement. Dialpad for Microsoft Teams is a cloud-native direct routing integration that seamlessly connects Dialpad’s enterprise-grade telephony features and award-winning Voice Intelligence (Vi™) capabilities into the Microsoft Teams native environment. According to Microsoft’s Hybrid Work Trend Index, workers report that their productivity has either remained the same or increased over the past year. As work methods continue to evolve, Dialpad is at the forefront, creating better, smarter and more seamless communication experiences. With Dialpad direct routing at the heart of the integration, Microsoft Teams users have access to Dialpad’s global calling capabilities with PSTN connectivity in 49 countries in addition to sophisticated inbound and outbound calling features. Powered by automatic spe
LiveArt Market Opens Trading16.6.2021 21:00:00 CEST | Press release
LiveArt is pleased to announce the public launch of LiveArt Market, the digital peer-to-peer marketplace that places control into the hands of sellers and buyers. LiveArt Market began limited, invitation-only trading last week and has already achieved sales approaching $5 million, with more than 1,000 works of art valued at approximately $120 million in the pipeline for sale. Prices have ranged between $50,000 and $500,000, with works by Amoako Boafo and Ed Clark commanding six-figure sums. Early offerings available for purchase include works by Derrick Adams, Jean-Michel Basquiat, Yayoi Kusama, Pablo Picasso and Andy Warhol, among others. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210616005925/en/ Yayoi Kusama, Little Flower, 1952, Gouache, pastel, ink, pen on paper, 11.5 x 8.5 in (Photo: Business Wire) LiveArt puts collectors in control by providing participants with one destination for real-time information and an eff